Inovio Pharmaceuticals, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
INO on Nasdaq
Location
6769 Mesa Ridge Rd., San Diego, CA

There are no Buy or Sell transactions made by insiders since 11/23/2023

Inovio Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jong Joseph Kim Chief Executive Officer, Director $2.45M Mar 11, 2022
David B. Weiner Director $1.11M May 21, 2024
Jacqueline E. Shea Chief Executive Officer, Director $818K May 15, 2024
Peter Kies Cfo $448K May 15, 2024
Laurent Humeau Chief Scientific Officer $443K May 15, 2024
Simon X. Benito Director $159K May 21, 2024
Michael John Sumner Chief Medical Officer $146K Jun 30, 2024
Wendy L. Yarno Director $137K May 21, 2024
Ann C. Miller Director $129K May 21, 2024
Jay Shepard Director $120K May 21, 2024
Roger D. Dansey Director $117K May 21, 2024
Lota S. Zoth Director $114K May 21, 2024

Recent Insider Transactions by Companies or Individuals for Inovio Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.